All Updates

As lawmakers dive into the 2024 legislative session, the American Cancer Society Cancer Action Network (ACS CAN) urges legislators to prioritize passing legislation to ease the burden of cancer on Hoosiers.

As lawmakers dive into the 2024 legislative session, the American Cancer Society Cancer Action Network (ACS CAN) urges legislators to prioritize passing legislation to ease the burden of cancer on Buckeyes.

ATLANTA, Ga. – January 5, 2024 – Statement from Julie Vojtech , American Cancer Society Cancer Action Network (ACS CAN) Georgia government relations director: “As Georgia lawmakers dive into the 2024 legislative session, ACS CAN urges them to prioritize legislation to ease the burden of cancer on Georgians. Georgia

The American Cancer Society Cancer Action Network (ACS CAN) announces two new members –– alongside newly-elected leadership officers to the Board of Directors, with terms that began on January 1, 2024. The Board provides leadership and guidance for ACS CAN, the advocacy affiliate of the American Cancer Society, which supports evidence-based policy and legislative solutions designed to end cancer as we know it, for everyone.

Hoy, la Corte de Apelaciones del Segundo Circuito de los EE. UU. escuchará los argumentos orales en el caso Haller versus el Departamento de Salud y Servicios Humanos (HHS, siglas en inglés) y decidirá si confirma o no el fallo del Tribunal de Distrito de los EE. UU. que mantiene la Ley Sin Sorpresas (NSA), legislación que prohíbe que los pacientes reciban facturas sorpresa por costos imprevistos fuera de la red.

Hoy, la Corte de Apelaciones del Segundo Circuito de los EE. UU. escuchará los argumentos orales en el caso Haller versus el Departamento de Salud y Servicios Humanos (HHS, siglas en inglés) y decidirá si confirma o no el fallo del Tribunal de Distrito de los EE. UU. que mantiene la Ley Sin Sorpresas (NSA), legislación que prohíbe que los pacientes reciban facturas sorpresa por costos imprevistos fuera de la red.

ALBANY, NY – DECEMBER 22, 2023 – Today, Governor Kathy Hochul signed Senate Bill 1196a / Assembly Bill 1673a into law, securing a major win for patients across New York. The new law will require all state-regulated health plans, including Medicaid, to cover comprehensive biomarker testing, which will enable

ANNAPOLIS, MD – DECEMBER 20, 2023 – On January 1, 2024, Marylanders will gain access to biomarker testing when Chapter 322 of the Laws of 2023 takes effect for private insurers. The legislation, which requires coverage of biomarker testing when supported by scientific and medical evidence, received near-unanimous support